Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhTPO and Sequential Eltrombopag for SAA/TD-NSAA
NCT07001397Phase 3Not yet recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jun 2025
- Primary completion
- Mar 2026
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of eltrombopag in aplastic anemia, sponsored by Peking Union Medical College Hospital. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
eltrombopag
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on NCT07001397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07001397.